Decatur Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.72M | Hold |
4,235
| – | – | 0.75% | 33 |
|
2025
Q1 | $2.11M | Buy |
4,235
+10
| +0.2% | +$4.98K | 1.09% | 27 |
|
2024
Q4 | $2.2M | Sell |
4,225
-62
| -1% | -$32.3K | 1% | 29 |
|
2024
Q3 | $2.65M | Buy |
4,287
+5
| +0.1% | +$3.09K | 1.22% | 24 |
|
2024
Q2 | $2.37M | Buy |
4,282
+114
| +3% | +$63K | 1.15% | 25 |
|
2024
Q1 | $2.42M | Sell |
4,168
-42
| -1% | -$24.4K | 1.32% | 22 |
|
2023
Q4 | $2.23M | Buy |
4,210
+307
| +8% | +$163K | 1.34% | 23 |
|
2023
Q3 | $1.98M | Hold |
3,903
| – | – | 1.43% | 20 |
|
2023
Q2 | $2.04M | Sell |
3,903
-55
| -1% | -$28.7K | 1.39% | 21 |
|
2023
Q1 | $2.28M | Sell |
3,958
-755
| -16% | -$435K | 1.72% | 13 |
|
2022
Q4 | $2.6M | Hold |
4,713
| – | – | 1.87% | 13 |
|
2022
Q3 | $2.39M | Buy |
4,713
+1
| +0% | +$507 | 1.81% | 13 |
|
2022
Q2 | $2.56M | Hold |
4,712
| – | – | 1.89% | 12 |
|
2022
Q1 | $2.78M | Buy |
4,712
+459
| +11% | +$271K | 1.62% | 13 |
|
2021
Q4 | $2.84M | Sell |
4,253
-50
| -1% | -$33.4K | 1.68% | 14 |
|
2021
Q3 | $2.46M | Sell |
4,303
-5,128
| -54% | -$2.93M | 1.62% | 15 |
|
2021
Q2 | $4.76M | Hold |
9,431
| – | – | 1.49% | 16 |
|
2021
Q1 | $4.3M | Sell |
9,431
-8,524
| -47% | -$3.89M | 1.48% | 17 |
|
2020
Q4 | $8.36M | Sell |
17,955
-400
| -2% | -$186K | 1.53% | 15 |
|
2020
Q3 | $8.1M | Buy |
+18,355
| New | +$8.1M | 1.6% | 13 |
|